These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9437458)

  • 1. Economic research on Alzheimer disease: a review of the literature.
    Ernst RL; Hay JW
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 6():135-45. PubMed ID: 9437458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economics of Alzheimer disease.
    Leung GM; Yeung RY; Chi I; Chu LW
    Dement Geriatr Cogn Disord; 2003; 15(1):34-43. PubMed ID: 12457077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of Alzheimer's disease in managed care: a cross-sectional study.
    Leon J; Neumann PJ
    Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
    Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
    Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a weekend respite program for persons with Alzheimer disease.
    Perry J; Bontinen K
    Can J Nurs Res; 2001 Jun; 33(1):81-95. PubMed ID: 11928159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients.
    Beeri MS; Werner P; Davidson M; Noy S
    Int J Geriatr Psychiatry; 2002 May; 17(5):403-8. PubMed ID: 11994927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy.
    Cavallo MC; Fattore G
    Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):184-90. PubMed ID: 9437435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.
    Rice DP; Fillit HM; Max W; Knopman DS; Lloyd JR; Duttagupta S
    Am J Manag Care; 2001 Aug; 7(8):809-18. PubMed ID: 11519239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of costs of care for patients with Alzheimer's disease.
    Jönsson L; Eriksdotter Jönhagen M; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
    Int J Geriatr Psychiatry; 2006 May; 21(5):449-59. PubMed ID: 16676288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contingent valuation method in health care. An economic evaluation of Alzheimer's disease.
    Nocera S; Telser H; Bonato D
    Dev Health Econ Public Policy; 2003; 8():iii-xi, 1-116. PubMed ID: 15027158
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessing the societal impact of acetylcholinesterase inhibitor therapies.
    Winblad B; Wimo A
    Alzheimer Dis Assoc Disord; 1999 Nov; 13 Suppl 2():S9-19. PubMed ID: 10622674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disability in Alzheimer's disease: causes, consequences, and economic considerations.
    Demakis GJ
    J Health Hum Serv Adm; 2007; 30(3):292-305. PubMed ID: 18236705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of Alzheimer's disease in a developing country setting.
    Zencir M; Kuzu N; Beşer NG; Ergin A; Catak B; Sahiner T
    Int J Geriatr Psychiatry; 2005 Jul; 20(7):616-22. PubMed ID: 16021668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
    Bullock R
    Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis in oncology.
    Evans WK
    Praxis (Bern 1994); 2000 Mar; 89(12):492-6. PubMed ID: 10771589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The costs and social burdens of Alzheimer disease: what can and should be done?
    Hay JW; Sano M; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):181-3. PubMed ID: 9437434
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of the scales of measures, the efficacy of the treatments and the health/social impact of Alzheimer disease in the Basque Country, Spain].
    Gutiérrez Iglesias MA; Aizpurua Imaz I; Moracho del Río O; Asua Batarrita J
    Med Clin (Barc); 2000; 114 Suppl 3():93-8. PubMed ID: 10994571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between severity of Alzheimer's disease and costs of caring.
    Hux MJ; O'Brien BJ; Iskedjian M; Goeree R; Gagnon M; Gauthier S
    CMAJ; 1998 Sep; 159(5):457-65. PubMed ID: 9757169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A profile of the burdens of care of Alzheimer's disease patients.
    Winblad B
    Eur Neuropsychopharmacol; 1999 Apr; 9 Suppl 2():S39-41. PubMed ID: 10332933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.